Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Maxpro Ventures is a biomedical technology investment firm established in 2013 and headquartered in Taipei, Taiwan. The firm focuses on identifying and investing in companies that develop innovative drugs, devices, diagnostics, and services aimed at addressing unmet medical needs. Maxpro Ventures has built a reputation for its global investment approach, targeting a wide range of companies from early-stage startups to late-stage multinational corporations.
As of now, Maxpro Ventures manages a diverse portfolio of 34 companies, showcasing its commitment to advancing healthcare technologies. The firm has successfully navigated the complexities of the biomedical landscape, providing both capital and strategic guidance to its portfolio companies. This dual approach enhances the potential for growth and innovation within the healthcare sector.
Maxpro Ventures has achieved notable milestones since its inception, including investments in breakthrough technologies that have the potential to transform patient care. The firm’s office is located in Taipei City, Taiwan, and it continues to expand its reach within the global healthcare market.
Maxpro Ventures invests primarily in breakthrough biomedical technology companies, with a strong emphasis on next-generation cell and gene therapies, biologic drugs, medical devices, diagnostics, and healthcare services. The firm operates across various investment stages, including pre-seed, seed, Series A, Series B, Series C, and growth equity. This broad stage focus allows Maxpro Ventures to engage with companies at different points in their development, providing tailored support based on their specific needs.
The firm seeks to partner with innovative companies that are addressing significant medical challenges. Maxpro Ventures looks for founders who demonstrate a strong vision and the capability to execute their ideas effectively. The firm provides not only capital but also strategic guidance to accelerate the development of its portfolio companies, ensuring they have the resources necessary to succeed in a competitive market.
Maxpro Ventures has a diverse portfolio that includes a total of 34 companies, reflecting its commitment to advancing healthcare technologies. Notable portfolio companies include:
This portfolio spans various sectors within healthcare, showcasing Maxpro Ventures' commitment to supporting innovative solutions that address unmet medical needs.
Moses Chen, Ph.D. - Managing Partner. Moses has extensive experience in biomedical investments and has led numerous successful funding rounds in the healthcare sector.
Francis Chung, Ph.D., MBA - Managing Partner. Francis combines his scientific background with business acumen, having previously worked in both academia and industry.
Alex Chen, MS, MBA - Managing Partner. Alex has a strong track record in venture capital and has been instrumental in identifying promising healthcare startups.
Aimee Chen, MS - Partner, General Manager China. Aimee oversees operations in China and has a deep understanding of the regional healthcare market.
Pin I Wu, LL.M. - Manager. Pin brings legal expertise to the team, ensuring compliance and strategic alignment in investments.
Claudia Huang, Ph.D. - Assistant Vice President. Claudia focuses on portfolio management and supports companies in their growth trajectories.
Ying Chen, MS - Assistant Vice President. Ying specializes in market analysis and helps identify investment opportunities within the healthcare sector.
Huei-Ling Liu, Ph.D. - Manager. Huei-Ling contributes scientific insights and supports due diligence processes for potential investments.
To pitch to Maxpro Ventures, founders should send their business plans to BP@maxproventures.com. The pitch deck should include a detailed overview of the business, market analysis, competitive landscape, and team background. Maxpro Ventures prefers clear and concise presentations that effectively communicate the value proposition and potential impact of the technology.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are beneficial, but not strictly necessary for submission.
In recent months, Maxpro Ventures has continued to expand its portfolio, adding several innovative companies in the biomedical technology sector. The firm remains active in identifying and supporting healthcare solutions that address unmet medical needs.
Maxpro Ventures has also been involved in discussions regarding potential partnerships with other investment firms to enhance its reach and impact within the healthcare market. These collaborations aim to leverage shared expertise and resources to accelerate the development of promising technologies.
What are Maxpro Ventures' investment criteria?
Maxpro Ventures focuses on breakthrough biomedical technology companies, particularly in next-generation cell and gene therapies, biologic drugs, medical devices, diagnostics, and healthcare services. The firm invests across various stages, from pre-seed to growth equity.
How can I apply or pitch to Maxpro Ventures?
Founders can submit their business plans via email to BP@maxproventures.com. It is advisable to include a comprehensive overview of the business, market potential, and team background in the pitch.
What makes Maxpro Ventures different from other investors?
Maxpro Ventures combines capital investment with strategic guidance, enhancing the growth potential of its portfolio companies. The firm’s focus on the biomedical sector allows it to provide specialized support tailored to the unique challenges of healthcare innovation.
What is the geographic scope of Maxpro Ventures' investments?
The firm invests globally, targeting innovative healthcare solutions from various regions. This global perspective enables Maxpro Ventures to identify and support a diverse range of companies.
What is the typical check size for investments?
While specific check sizes are not disclosed, Maxpro Ventures invests across multiple stages, which typically involves varying amounts depending on the stage of the company and its specific needs.
What kind of post-investment involvement does Maxpro Ventures have?
Maxpro Ventures provides ongoing strategic guidance and support to its portfolio companies, helping them navigate challenges and accelerate their growth in the competitive healthcare market.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.